Publicaciones (26) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. Advancing with cancer immunotherapeutics: CD29+ regulatory T cell antagonism

    Gut

  2. Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis (Nature Communications, (2019), 10, 1, (3126), 10.1038/s41467-019-11004-3)

    Nature Communications

  3. Author Correction: Long-term retention of antigens in germinal centers is controlled by the spatial organization of the follicular dendritic cell network (Nature Immunology, (2023), 24, 8, (1281-1294), 10.1038/s41590-023-01559-1)

    Nature Immunology

  4. Correction: Adipose tissue specific CCL18 associates with cardiometabolic diseases in non-obese individuals implicating CD4+ T cells (Cardiovascular Diabetology, (2023), 22, 1, (84), 10.1186/s12933-023-01803-w)

    Cardiovascular Diabetology

  5. Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)

    Leukemia

  6. Correction: The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer (Molecular Cancer, (2023), 22, 1, (86), 10.1186/s12943-023-01788-w)

    Molecular Cancer

  7. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

  8. Corrigendum to “Development of intranasal implantable devices for schizophrenia treatment” [Int. J. Pharm. 624 (2021) 122061] (International Journal of Pharmaceutics (2022) 624, (S0378517322006159), (10.1016/j.ijpharm.2022.122061))

    International Journal of Pharmaceutics

  9. Dendritic cells, headhunters for anti-tumor CD8+ T cells in triple-negative breast cancer

    Med

  10. Disease Monitoring In Multiple Myeloma

    Clinical Lymphoma, Myeloma and Leukemia

  11. Editorial: Long non-coding RNAs in viral infections and immunity

    Frontiers in Immunology

  12. Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies(Front. Immunol., (2023), 13, (1044025), 10.3389/fimmu.2022.1044025)

    Frontiers in Immunology

  13. Estrogen Receptor and Immune Checkpoint Inhibitors: New Partners in Lung Cancer?

    Clinical cancer research : an official journal of the American Association for Cancer Research

  14. Frontiers in fatty liver: recent advances in pathogenic mechanisms, assessment of patients’ prognosis and pharmacotherapy: MASLD: new pathogenic mechanisms, risk assessment tools and drug therapies

    Journal of Physiology and Biochemistry

  15. Highs and lows of t(4;14) in multiple myeloma

    Blood

  16. In situ detection of vaccine mRNA in the cytoplasm of hepatocytes during COVID-19 vaccine-related hepatitis

    Journal of Hepatology

  17. MicroRNA-223: A key regulator of liver tumour microenvironment

    Gut

  18. More than shots in the dark: improving patient stratification to move closer to personalised therapies in intrahepatic cholangiocarcinoma

    Gut

  19. Mutated trimeric RBD vaccines: a platform against variants of concern

    Signal Transduction and Targeted Therapy

  20. Primary trimethylaminuria syndrome: more than an unpleasant odor

    International Journal of Dermatology